Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study

Table 4 Detailed data of patients treated with preoperative TAE

Case	Age	Sex	Etiology	Tumor location	Tumor size (mm)	Frequency of TAE	Time to surgery (month)	Shrinkage rate (%)	Necrosis rate (%)	Recurrence	RFS (month)	Disease-specific death	DSS (month)
1	63	M	Alc	AP	110	1	3.2	− 22.7	40	+	40	-	137
2	71	M	Alc	AP	150	3	7.4	− 23.3	90	+	83	-	99
3	63	M	HCV	AP	240	3	5.1	− 45.8	90	-	39	-	39
4	78	M	HBV	P	120	3	6.4	− 54.2	100	-	25	-	25
5	65	M	Alc	PA	110	2	11.9	− 7.4	100	-	9	-	9

Tumor size is pre-TAE value
TAE trans-arterial embolization, M male, Alc alcoholic hepatitis, HCV hepatitis C virus-induced hepatitis, HBV hepatitis B virus-induced hepatitis, A anterior segment, P posterior segment, RFS recurrence-free survival, DSS disease-specific survival

ISSN: 1477-7819